These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1356725)

  • 21. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the antipyrine test in laboratory animals. Studies in the dog and monkey.
    Vickers FF; Bowman TA; Dvorchik BH; Passananti GT; Hughes DM; Vesell ES
    Drug Metab Dispos; 1989; 17(2):160-5. PubMed ID: 2565205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipyrine pharmacokinetics and urinary excretion in female horses.
    Dyke TM; Sams RA; Hinchcliff KW
    Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
    van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
    Shaw PN; Hall ST; Houston JB
    Xenobiotica; 1986 Dec; 16(12):1109-16. PubMed ID: 3798958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.
    Teunissen MW; Brorens IO; De Langen HJ; Geerlings AM; Breimer DD
    Pharm Res; 1986 Jun; 3(3):156-61. PubMed ID: 24271521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise training does not alter cytochrome P-450 content and microsomal metabolism.
    Michaud TJ; Bachmann KA; Andres FF; Flynn MG; Sherman GP; Rodriguez-Zayas J
    Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
    Pfeifer A; Neumann HG
    Drug Metab Dispos; 1988; 16(2):276-84. PubMed ID: 2898347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
    Kahn GC; Boobis AR; Murray S; Davies DS
    Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
    Loft S; Poulsen HE
    Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro biotransformation of theobromine by phenobarbital- and 3-methylcholanthrene-inducible cytochrome P-450 monooxygenases in rat liver. Role of thiol compounds.
    Shively CA; Vesell ES
    Drug Metab Dispos; 1987; 15(2):217-24. PubMed ID: 2882982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
    Henderson DJ; van Bezooijen CF
    Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.